EP 1094810 A1 20010502 - USE OF PRENYLTRANSFERASE INHIBITORS FOR PREPARING A MEDICINE FOR TREATING PATHOLOGIES RESULTING FROM HETEROTRIMERIC G PROTEIN MEMBRANE FIXATION
Title (en)
USE OF PRENYLTRANSFERASE INHIBITORS FOR PREPARING A MEDICINE FOR TREATING PATHOLOGIES RESULTING FROM HETEROTRIMERIC G PROTEIN MEMBRANE FIXATION
Title (de)
VERWENDUNG VON PRENYLTRANSFERASE-INHIBITOREN ZUR HERSTELLUNG EINES ARZNEIMITTELS ZUR BEHANDLUNG VON KRANKHEITEN DIE, DURCH MEMBRANISCHE BEFESTIGUNG DER HETEROTRIMERISCHE-G-PROTEIN ENTSTEHEN
Title (fr)
UTILISATION D'INHIBITEURS DE PRENYLTRANSFERASES POUR PREPARER UN MEDICAMENT DESTINE A TRAITER LES PATHOLOGIES QUI RESULTENT DE LA FIXATION MEMBRANAIRE DE LA PROTEINE G HETEROTRIMERIQUE
Publication
Application
Priority
- FR 9901611 W 19990705
- FR 9808730 A 19980708
Abstract (en)
[origin: FR2780892A1] The invention concerns the use of prenyltransferase inhibitors for preparing a medicine for treating pathologies resulting from prenylation of the gamma subunit of G protein. Said diseases comprise in particular diseases related to the following biological functions or disorders: smell, taste, light perception, neurotransmission, neurodegeneration, endocrine and exocrine gland functioning, autocrine and paracrine regulation, blood pressure, embryogenesis, viral infection, immunological functions, diabetes and obesity.
IPC 1-7
A61K 31/425; A61K 31/215; A61K 31/47; A61K 31/535; A61K 31/55; A61K 31/66; A61K 31/445; A61K 31/42; A61K 31/495
IPC 8 full level
A61K 31/198 (2006.01); A61K 31/223 (2006.01); A61K 31/4178 (2006.01); A61K 31/423 (2006.01); A61K 31/426 (2006.01); A61K 31/4427 (2006.01); A61K 31/4545 (2006.01); A61K 31/4709 (2006.01); A61K 31/495 (2006.01); A61K 31/4985 (2006.01); A61K 31/5377 (2006.01); A61K 31/5513 (2006.01); A61K 31/662 (2006.01); A61K 38/00 (2006.01); A61K 45/00 (2006.01); A61P 1/12 (2006.01); A61P 3/04 (2006.01); A61P 3/10 (2006.01); A61P 5/00 (2006.01); A61P 9/00 (2006.01); A61P 15/00 (2006.01); A61P 25/02 (2006.01); A61P 25/28 (2006.01); A61P 31/04 (2006.01); A61P 31/12 (2006.01); A61P 31/18 (2006.01); A61P 37/02 (2006.01); A61P 43/00 (2006.01); C07D 241/04 (2006.01); C07D 277/06 (2006.01); C07D 401/06 (2006.01); C07D 403/06 (2006.01); C07D 513/04 (2006.01)
CPC (source: EP)
A61K 38/005 (2013.01); A61P 1/12 (2017.12); A61P 3/04 (2017.12); A61P 3/10 (2017.12); A61P 5/00 (2017.12); A61P 9/00 (2017.12); A61P 15/00 (2017.12); A61P 25/00 (2017.12); A61P 25/02 (2017.12); A61P 25/28 (2017.12); A61P 31/00 (2017.12); A61P 31/04 (2017.12); A61P 31/12 (2017.12); A61P 31/18 (2017.12); A61P 35/00 (2017.12); A61P 37/02 (2017.12); A61P 43/00 (2017.12); Y02A 50/30 (2017.12)
Citation (search report)
See references of WO 0002558A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
FR 2780892 A1 20000114; FR 2780892 B1 20010817; AU 4622499 A 20000201; CA 2337261 A1 20000120; EP 1094810 A1 20010502; JP 2002520284 A 20020709; NO 20010030 D0 20010103; NO 20010030 L 20010108; WO 0002558 A1 20000120
DOCDB simple family (application)
FR 9808730 A 19980708; AU 4622499 A 19990705; CA 2337261 A 19990705; EP 99929396 A 19990705; FR 9901611 W 19990705; JP 2000558818 A 19990705; NO 20010030 A 20010103